<DOC>
	<DOCNO>NCT01681615</DOCNO>
	<brief_summary>The investigator want find new challenge test Acetylsalicylic hypersensitivity / Aspirin hypersensitivity . The investigator suggest new test efficient already establish protocol term sensitivity specificity .</brief_summary>
	<brief_title>Challenge Test Acetylsalicylic Acid Hypersensitivity</brief_title>
	<detailed_description>Hypersensitivity Acetylsalicylic Acid Aspirin ( NSAIDS ) condition affect 2,5 % population . Most case see complex hypersensitivity chronic eosinophilic rhinosinusitis nasal polyposis asthma . Despite research find reliable in-vitro-test condition , challenge test still consider gold standard . So far oral , nasal , inhalation intravenous route administration describe literature .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Nasal Polyps</mesh_term>
	<mesh_term>Asthma , Aspirin-Induced</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Persons 18 60 year age Suspected Acetylsalicylic Acid Hypersensitivity History anaphylactic shock NSAIDS intake History gastric ulcer NSAIDS intake Patients previously go test desensitisation Aspirin hypersensitivity Clinical unstable asthma baseline FEV1 &lt; 70 % Severe disease heart , digestive tract , liver kidney Severe chronic urticaria Present conjunctivitis Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Challenge test Aspirin Hypersensitivity</keyword>
	<keyword>Challenge test Acetylsalicylic Hypersensitivity</keyword>
</DOC>